Viracta Therapeutics Inc (VIRX)
0.8102
-0.03
(-3.55%)
USD |
NASDAQ |
May 03, 16:00
0.822
+0.01
(+1.46%)
After-Hours: 20:00
Viracta Therapeutics Enterprise Value: 8.854M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 8.854M |
| May 02, 2024 | 10.02M |
| May 01, 2024 | 9.242M |
| April 30, 2024 | 9.223M |
| April 29, 2024 | 9.278M |
| April 26, 2024 | 9.564M |
| April 25, 2024 | 10.30M |
| April 24, 2024 | 9.878M |
| April 23, 2024 | 10.33M |
| April 22, 2024 | 11.59M |
| April 19, 2024 | 10.68M |
| April 18, 2024 | 12.73M |
| April 17, 2024 | 13.80M |
| April 16, 2024 | 5.107M |
| April 15, 2024 | 7.668M |
| April 12, 2024 | 22.20M |
| April 11, 2024 | 22.98M |
| April 10, 2024 | 21.81M |
| April 09, 2024 | 18.66M |
| April 08, 2024 | 19.06M |
| April 05, 2024 | 17.09M |
| April 04, 2024 | 17.88M |
| April 03, 2024 | 19.84M |
| April 02, 2024 | 19.84M |
| April 01, 2024 | 20.63M |
| Date | Value |
|---|---|
| March 28, 2024 | 17.09M |
| March 27, 2024 | 19.45M |
| March 26, 2024 | 19.45M |
| March 25, 2024 | 18.66M |
| March 22, 2024 | 15.13M |
| March 21, 2024 | 19.06M |
| March 20, 2024 | 21.41M |
| March 19, 2024 | 16.70M |
| March 18, 2024 | 15.91M |
| March 15, 2024 | 16.15M |
| March 14, 2024 | 15.13M |
| March 13, 2024 | 14.34M |
| March 12, 2024 | 15.72M |
| March 11, 2024 | 11.99M |
| March 08, 2024 | 10.43M |
| March 07, 2024 | 8.850M |
| March 06, 2024 | 13.15M |
| March 05, 2024 | 14.13M |
| March 04, 2024 | 13.95M |
| March 01, 2024 | 12.61M |
| February 29, 2024 | 8.896M |
| February 28, 2024 | 11.83M |
| February 27, 2024 | 6.746M |
| February 26, 2024 | 4.400M |
| February 23, 2024 | 4.400M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.62M
Minimum
Dec 29 2022
538.91M
Maximum
Feb 26 2021
74.01M
Average
18.66M
Median
Jan 12 2023
Enterprise Value Benchmarks
| XOMA Corp | 258.75M |
| Marinus Pharmaceuticals Inc | 5.632M |
| Cartesian Therapeutics Inc | 378.67M |
| Adial Pharmaceuticals Inc | 4.066M |
| NovaBay Pharmaceuticals Inc | 2.813M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.76M |
| Total Expenses (Quarterly) | 13.56M |
| EPS Diluted (Quarterly) | -0.35 |
| Earnings Yield | -162.9% |